CARMIL2
protein-codingcapping protein regulator and myosin 1 linker 2
Gene summary
This gene encodes a member of the CARMIL (capping protein, Arp2/3, myosin-I linker) family of proteins. The encoded protein interacts with and negatively regulates the heterodimeric capping protein and promotes cell migration. Reduced expression of this gene has been observed in human psoriasis patients. Mutations in this gene cause a human immunodeficiency syndrome characterized by smooth muscle tumors and impaired T-cell function. [provided by RefSeq, May 2017]
- RLTPR
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~12.6 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0029134
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0029134
Submitter: ClinGen
*CARMIL2 *(i.e., *RLTPR*) was first reported in relation to autosomal recessive severe combined immunodeficiency due to CARMIL2 deficiency in 2016 (Sorte HS et al., PMID: 27896283). Severe combined immunodeficiency due to CARMIL2 deficiency is a combined immunodeficiency with prominent immune dysregulation. This is a heterogeneous disorder characterized by failure to thrive, recurrent upper and lower respiratory infections, skin abnormalities (note the occurrence of these require infection and/or immune-mediated processes in addition to CARMIL2 defects), eczema, warts, seborrheic dermatitis, allergies, and asthma. Additional features of disease often observed include candidiasis, herpes infection, *Molloscum contagiosum* infection, early-onset inflammatory bowel disease, chronic diarrhea, and Epstein Barr virus-related smooth muscle tumors. Immunologically, these patients typically display impaired naïve T-cell activation, differentiation, proliferation, and effector function, and defective T-cell memory responses. More than 50 individuals with autosomal recessive severe combined immunodeficiency due to CARMIL2 deficiency have been reported to date (PMID: 34287962). Six variants (missense and frameshift) that have been reported in 7 probands in 3 publications (PMIDs: 27896283, 34287962, 36727012) are included in this curation. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. The mechanism of pathogenicity is known to be loss of function. This gene-disease relationship is also supported by animal models, expression studies, and in vitro functional assays (PMIDs: 23793062, 27647348, 27647349, 28112205). *CARMIL2* has been shown to be expressed in immune organs and T cells (PMID: 23793062, 27647349), function in CD28 signaling, and facilitate scaffold interactions with CD28 and CARD11 downstream of T-cell receptor stimulation (PMID: 27647348, 28112205). Two different mouse models demonstrate T-cell abnormalities when CARMIL2 is either deleted or mutated to impair function (PMID: 23793062, 27647348). T-cell abnormalities in cytokine production, proliferation, and migration have been observed in cells derived from many different patients (PMID: 27647349, 28112205). In summary, there is definitive evidence supporting the relationship between *CARMIL2* and autosomal recessive severe combined immunodeficiency due to CARMIL2 deficiency. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time.
Inheritance Pattern: AR
Disease ID:MONDO:0029134
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0029134
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0029134
Submitter: Ambry Genetics
Clinical Genomic Database (CGD)
Manifestation: Allergy/Immunology/Infectious; Dermatologic; Oncologic; Pulmonary
Intervention: Allergy/Immunology/Infectious; Oncologic
Rationale: Individuals may have severe and frequent infections, and prophylactic measures, as well as early and aggressive treatment of infections may be beneficial; Individuals may be at increased risk of certain types of neoplasms, and awareness may allow prompt diagnosis and management
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to CARMIL2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001013838.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 7 | 343 | 5 | 355 | ||
| missense | 1 | 5 | 446 | 23 | 5 | 480 |
| nonsense | 16 | 4 | 2 | 22 | ||
| start loss | 0 | |||||
| frameshift | 32 | 8 | 1 | 41 | ||
| splice donor/acceptor (+/-2bp) | 2 | 18 | 6 | 26 | ||
| Total | 51 | 35 | 462 | 366 | 10 | 924 |
Highest pathogenic variant AF is 0.0000487285
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001013860.1 | 38 | MANE Select | |
| Ensembl | ENSP00000334958.5 | 38 | MANE Select | |
| RefSeq | NP_001303955.1 | 38 | Standard | |
| RefSeq | NP_001425173.1 | 39 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- establishment or maintenance of cell polarity
- positive regulation of lamellipodium assembly
- maintenance of cell polarity
- positive regulation of cell migration
- wound healing, spreading of cells
Molecular Function
- phospholipid binding
- protein-containing complex binding
Cellular Component
- ruffle
- cytoplasm
- plasma membrane
- actin cytoskeleton
- membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000334583
- Coding exons
- 38
- Length
- 12651
- Individuals with no LoFs
- 124971
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 56
- Defined
- 125027
- p
- 0.000224
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.57 | 703 | 831 | 0.846 | 0.0000522 | 9032 |
| Missense (PolyPhen) | 179 | 236.34 | 0.7574 | 2931 | ||
| Synonymous | 0.774 | 346 | 365 | 0.948 | 0.0000242 | 3095 |
| Loss of Function | 4.81 | 32 | 77.8 | 0.411 | 0.00000445 | 803 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00056 | 0.00051 | rare |
| Latino/Admixed American | 0.000088 | 0.000087 | rare |
| Ashkenazi Jewish | 0.00010 | 0.000099 | rare |
| East Asian | 0.00029 | 0.00027 | rare |
| Finnish | 0.000093 | 0.000093 | rare |
| European (Non-Finnish) | 0.00029 | 0.00026 | rare |
| South Asian | 0.00024 | 0.00023 | rare |
| Other | 0.00017 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Cell membrane-cytoskeleton-associated protein that plays a role in the regulation of actin polymerization at the barbed end of actin filaments. Prevents F-actin heterodimeric capping protein (CP) activity at the leading edges of migrating cells, and hence generates uncapped barbed ends and enhances actin polymerization (PubMed:26466680). Plays a role in cell protrusion formations; involved in cell polarity, lamellipodial assembly, membrane ruffling and macropinosome formations (PubMed:19846667, PubMed:26578515, PubMed:26466680). Involved as well in cell migration and invadopodia formation during wound healing (PubMed:19846667, PubMed:26578515, PubMed:26466680). {ECO:0000269|PubMed:19846667, ECO:0000269|PubMed:26466680, ECO:0000269|PubMed:26578515}.;
Recessive Scores
- pRec
- 0.0922
Intolerance Scores
- RVIS EVS
- -1.12
- RVIS percentile EVS
- 6.61
Essentials
- Essential (gene trap)
- N